Literature DB >> 17948258

Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha6beta4 and alpha3beta1 integrins.

Carlo Bergamini1, Concetta Sgarra, Paolo Trerotoli, Luigi Lupo, Amalia Azzariti, Salvatore Antonaci, Gianluigi Giannelli.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) growth severely affects prognosis. Ki-67, a known marker of cell proliferation, is a negative prognostic factor in HCC. Growth factors such as the epidermal growth factor (EGF) induce HCC cell proliferation but do not explain the great heterogeneity of HCC growth. Laminin-5 (Ln-5) is an extracellular matrix protein (ECM) present in the tissue microenvironment of HCC. The two main receptors for Ln-5, integrins alpha3beta1 and alpha6beta4, are expressed on the cell surface of HCC cells. The aim of this study is to investigate an alternative mechanism of HCC growth whereby Ln-5 promotes HCC cell proliferation through alpha3beta1 and alpha6beta4. HCC tissues containing Ln-5 display a larger diameter and higher number of positive cells for Ki-67, a well known proliferative index, as determined by double immunofluorescence staining and real-time PCR on microdissected tissues. In vitro, Ln-5, but not collagen I, collagen IV or fibronectin, induces proliferation as much as EGF does, via Erk phosphorylation as a consequence of beta4 integrin phosphorylation. However, the two HCC cell lines do not proliferate in presence of Ln-5 despite beta4 integrin and Erk1/2 activation. After transfection with alpha3 integrin, in the presence of Ln-5 one of these HCC cell lines acquires a proliferative activity whereas one of the proliferative HCC cell lines, knocked-down for alpha3 integrin, loses its proliferative activity.
CONCLUSIONS: Our study suggests a new mechanism of HCC growth whereby Ln-5 stimulates proliferation via a different function of alpha6beta4 and alpha3beta1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948258     DOI: 10.1002/hep.21936

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

Review 1.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.

Authors:  Carmen Berasain; Matías A Avila
Journal:  J Gastroenterol       Date:  2013-12-10       Impact factor: 7.527

Review 3.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Authors:  Ju Dong Yang; Ikuo Nakamura; Lewis R Roberts
Journal:  Semin Cancer Biol       Date:  2010-10-12       Impact factor: 15.707

Review 4.  Epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Franziska van Zijl; Gudrun Zulehner; Michaela Petz; Doris Schneller; Christoph Kornauth; Mara Hau; Georg Machat; Markus Grubinger; Heidemarie Huber; Wolfgang Mikulits
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

5.  Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.

Authors:  Yun Zhang; Jing Zhao; Jing Cai; Jia-Cong Ye; Yi-Tai Xiao; Yan Mei; Mu-Sheng Zeng; Chuan-Miao Xie; Yong Jiang; Guo-Kai Feng
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

6.  Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

Authors:  Francesco Dituri; Antonio Mazzocca; Joan Fernando; Fernando Juan Peidrò; Patrizia Papappicco; Isabel Fabregat; Flavia De Santis; Angelo Paradiso; Carlo Sabbà; Gianluigi Giannelli
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

7.  Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models.

Authors:  Keane K Y Lai; Sufen Shang; Neha Lohia; Garrett C Booth; Derek J Masse; Nelson Fausto; Jean S Campbell; Laura Beretta
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

8.  Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.

Authors:  Iwata Ozaki; Hiroshi Hamajima; Sachiko Matsuhashi; Toshihiko Mizuta
Journal:  Front Physiol       Date:  2011-10-24       Impact factor: 4.566

9.  The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.

Authors:  Norio Yamakawa; Kazuko Kaneda; Yusuke Saito; Emi Ichihara; Kazuhiro Morishita
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

10.  Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.

Authors:  Yang You; Qiongdan Zheng; Yinying Dong; Yaohui Wang; Lan Zhang; Tongchun Xue; Xiaoying Xie; Chao Hu; Zhiming Wang; Rongxin Chen; Yanhong Wang; Jiefeng Cui; Zhenggang Ren
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.